The research of cancer immunotherapy has been very hot in recent years, especially immune checkpoint inhibitors have been quite mature as the first generation of immunotherapy, they play a therapeutic role in various cancers through mainly blocking PD-1/PD-L1 pathway and molecular receptors and/or ligands such as CTLA-4 (Topalian et al., 2015). The gene discussed is CD274; the disease is cancer.